On December 31, 2012, Jazz Pharmaceuticals (JAZZ) had a market capitalization of $3.3B, based on 62.3M shares at a price of $53.25.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2012 | $53.25 | 11,538,500 | 62,300,000 | $3,317,475,000.00 |
November 2012 | $53.88 | 10,384,300 | 62,300,000 | $3,356,724,000.00 |
October 2012 | $53.62 | 9,276,200 | 62,300,000 | $3,340,526,000.00 |
September 2012 | $57.00 | 23,481,000 | 60,883,000 | $3,470,331,000.00 |
August 2012 | $45.51 | 15,448,000 | 60,883,000 | $2,770,785,330.00 |
July 2012 | $48.07 | 10,372,400 | 60,883,000 | $2,926,645,810.00 |
June 2012 | $45.01 | 18,453,300 | 60,554,000 | $2,725,535,540.00 |
May 2012 | $43.20 | 19,909,100 | 60,554,000 | $2,615,932,800.00 |
April 2012 | $51.03 | 20,138,000 | 60,554,000 | $3,090,070,620.00 |
March 2012 | $48.47 | 21,816,200 | 58,084,000 | $2,815,331,480.00 |
February 2012 | $52.47 | 20,293,800 | 58,084,000 | $3,047,667,480.00 |
January 2012 | $46.50 | 22,358,100 | 58,084,000 | $2,700,906,000.00 |
December 2011 | $38.63 | 10,997,400 | 47,500,000 | $1,834,925,000.00 |
November 2011 | $39.62 | 16,324,400 | 47,500,000 | $1,881,950,000.00 |
October 2011 | $38.96 | 17,975,100 | 47,500,000 | $1,850,600,000.00 |
September 2011 | $41.50 | 18,845,900 | 47,241,000 | $1,960,501,500.00 |
August 2011 | $42.89 | 24,440,900 | 47,241,000 | $2,026,166,490.00 |
July 2011 | $40.47 | 13,840,300 | 47,241,000 | $1,911,843,270.00 |
June 2011 | $33.35 | 14,579,000 | 46,601,000 | $1,554,143,350.00 |
May 2011 | $29.29 | 19,616,300 | 46,601,000 | $1,364,943,290.00 |
April 2011 | $31.91 | 15,144,700 | 46,601,000 | $1,487,037,910.00 |
March 2011 | $31.85 | 21,864,300 | 45,697,000 | $1,455,449,450.00 |
February 2011 | $24.63 | 12,845,200 | 45,697,000 | $1,125,517,110.00 |
January 2011 | $22.36 | 15,076,700 | 45,697,000 | $1,021,784,920.00 |
December 2010 | $19.68 | 10,917,500 | 43,400,000 | $854,112,000.00 |